The immune checkpoint gene CXCL1 shows statistically significant differences between subtype A (Cluster 1) and subtype B (Cluster 2) in cervical cancer (CESC) samples (p value < 0.001) (Figure 6A). The gene discussed is CXCL1; the disease is cervical squamous cell carcinoma.